Return to homepagePandemic Pact

ACE2-S-Cov Inhibition of the SARS-Cov2-S and ACE2 interaction

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    ANR

  • Principal Investigator

    Unspecified Hugues de Rocquigny

  • Research Location

    France

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The ACE2-S-Cov project aims to evaluate the effect of a series of patented molecules targeting the SARS-CoV-2 - S protein and ACE2 interaction. It brings together researchers with complementary skills in drug design, medicinal chemistry and virology, to identify compounds with potent antiviral effects.